C. R. Ganellin

Publications222
h-index41
Citations7,183
Highly Influential Citations230
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Schwartz
  • 345 Publications, 21,102 Citations
  • W. Schunack
  • 601 Publications, 7,483 Citations
  • M. Garbarg
  • 166 Publications, 7,555 Citations
  • H. Stark
  • 437 Publications, 16,544 Citations
  • Publications
  • Influence
International Union of Pharmacology. XIII. Classification of histamine receptors.
The classification of histamine receptors has to date been based on rigorous classical pharmacological analysis, and as yet, the classification of the three histamine receptors that have been defined… Expand
  • 852
  • 53
  • PDF
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology
Histamine H3 receptor inverse agonists are known to enhance the activity of histaminergic neurons in brain and thereby promote vigilance and cognition.… Expand
  • 183
  • 20
  • PDF
Histamine and its receptors
This article reviews the development of our knowledge of the actions of histamine which have taken place during the course of the 20th century. Histamine has been shown to have a key physiological… Expand
  • 379
  • 19
Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
Ciproxifan, i.e., cyclopropyl-(4-(3-1H-imidazol-4-yl)propyloxy) phenyl) ketone, belongs to a novel chemical series of histamine H3-receptor antagonists. In vitro, it behaved as a competitive… Expand
  • 229
  • 18
  • PDF
Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists.
A rational approach to the design of centrally acting agents is presented, based initially upon a comparison of the physicochemical properties of three typical histamine H2 receptor antagonists which… Expand
  • 433
  • 12
Characterization and inhibition of a cholecystokinin-inactivating serine peptidase
A cholecystokinin (CCK)-inactivating peptidase was purified and identified as a membrane-bound isoform of tripeptidyl peptidase II (EC 3.4.14.10), a cytosolic subtilisin-like peptidase of previously… Expand
  • 168
  • 12
Protean agonism at histamine H3 receptors in vitro and in vivo
G protein-coupled receptors (GPCRs) are allosteric proteins that adopt inactive (R) and active (R*) conformations in equilibrium. R* is promoted by agonists or occurs spontaneously, leading to… Expand
  • 132
  • 11
  • PDF
Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain
Starting from the sequence of the human histamine H3 receptor (hH3R) cDNA, we have cloned the corresponding rat cDNA. Whereas the two deduced proteins show 93.5% overall homology and differ only by… Expand
  • 141
  • 8
S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
The effects of a new agonist of histamine (HA) H3 receptors, Imetit (S-[2-(4-(imidazolyl)ethyl]isothiourea) were investigated in vitro and in vivo and compared to those of (R)-alpha-methylhistamine… Expand
  • 153
  • 8
Enhancement of Hippocampal Pyramidal Cell Excitability by the Novel Selective Slow-Afterhyperpolarization Channel Blocker 3-(Triphenylmethylaminomethyl)pyridine (UCL2077)
The slow afterhyperpolarization (sAHP) in hippocampal neurons has been implicated in learning and memory. However, its precise role in cell excitability and central nervous system function has not… Expand
  • 45
  • 7
  • PDF